Yayın:
Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy

dc.contributor.authorMehlika Dilek Altıntop
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorİpek Ertorun
dc.contributor.authorErtorun, İpek
dc.contributor.authorGülşen Akalın Çiftçi
dc.contributor.authorÇiftçi, Gülşen Akalın
dc.contributor.authorAhmet Özdemır
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.orcid0000-0002-8159-663X
dc.contributor.orcid0000-0001-8328-4157
dc.contributor.orcid0000-0001-5098-8967
dc.contributor.orcid0000-0003-0280-5550
dc.date.accessioned2025-11-13T09:50:12Z
dc.date.issued2024-07-20
dc.identifier.doi10.1016/j.ejmech.2024.116698
dc.identifier.endpage116698
dc.identifier.issn0223-5234
dc.identifier.openalexW4400852618
dc.identifier.pubmed39047611
dc.identifier.scopus2-s2.0-85199215448
dc.identifier.startpage116698
dc.identifier.urihttps://hdl.handle.net/11421/2337
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2024.116698
dc.identifier.volume276
dc.identifier.wos001278870300001
dc.language.isoen
dc.relation.ispartofEuropean Journal of Medicinal Chemistry
dc.rightsopenAccess
dc.subjectChemistry
dc.subjectHydrazone
dc.subjectDual (grammatical number)
dc.subjectProtein kinase B
dc.subjectSeries (stratigraphy)
dc.subjectHybrid
dc.subjectPharmacology
dc.subjectStereochemistry
dc.subjectPhosphorylation
dc.subjectBiochemistry
dc.subjectBotany
dc.subjectBiology
dc.titleDesign, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5048968214
local.authorid.openalexA5035115463
local.authorid.openalexA5045943806
local.authorid.openalexA5100651829

Dosyalar

Koleksiyonlar